The Sanner Group recently held the groundbreaking ceremony for a new production site and headquarters in Bensheim, Germany, and a second manufacturing facility in Kunshan, China, which is due to start production this summer.

These expansions will support Sanner’s key strategic pillars: continue to enhance the packaging and desiccant portfolio for the healthcare market and to increase activities as a device CDMO with more space for fully automated production and assembly of medical technology, diagnostics, and pharma drug delivery solutions.

With construction now underway, the business is due to transition all production to the new, facility in September 2024. The building is centrally positioned to access key logistics routes.

The new site in Bensheim will have 30,000 square metres of the production floor, doubling Sanner’s existing German capacity. New highly automated equipment will further increase production capacity by even more than 100 per cent. The new facility will have the following capabilities:

300 square meters for a new technology and innovation centre (“Sanner Technikum”), where customer-specific solutions and prototypes will be developed,

Separate desiccant and injection moulding areas,

A flexible moulding and assembly production floor to adapt to customer needs in both the packaging and device CDMO areas,

An automated central material supply to feed all machines,

Class 7 and 8 clean room capacity,

ESD floors for electronic medical device components,

Double the current warehouse capacity with a fully automated stock management system.